Sonovia Ltd.

Investor Presentation • Dec 9, 2020

COMPANY'S PRESENTATION NOVEMBER 2020

NOVEL ANTI-VIRAL & OTHER TEXTILE APPLICATIONS

Sonovia was established in 2013 for the commercialization of two Bar-Ilan University patents which had been approved for innovation in the area of anti-bacterial fabric coating.

The commercialization of the knowledge was made following the completion of an R&D project led by Bar-Ilan research team. The project received Euro 8.3 million in funding from the European Union. Sonovia's technology is used for:

bacterial and antiviral coating for [99% effective against Cov-19]

ABOUT THE COMPANY

*Un-audited numbers

Sonovia's leadership team consists of leading experts in the areas of management, chemistry, engineering, textile, business development and strategy, who led the Company to substantial technological and business accomplishments.

OUR TEAM

Dr. Aaron Garzon VP R&D

Shuki Hershkovitz Founder and CEO

CTO

Prof. Sidney Altman Advisor (Nobel Prize Winner)

Roy Hirsch CBO

Dana Yaacov Garbeli, CPA

CFO

Asaf Levy Head of Sales Division

Leading the global fight against epidemics and acquired infections alongside the development and commercialization of advanced applications for the textile industry.

Sonovia's ground breaking technology provides an environmental friendly alternative for advanced applicative textile treatments.

OUR VISION

Textiles are soaked in a chemical solution consisting of active agents [pigment, for instance] and chemical binders which bind the active agents to the textiles

How does it currently work?

Applicative Textile Treatments are chemical treatments granting the textiles with certain properties such as color, water repellence and fire retardancy

What are Applicative Textile Treatments?

In almost every product in the textile industry, which is valued at USD 1.9 trillion per year, encompassing from clothing and bedding up to car seats

Where are Textile Applications used?

Sonovia uses ultrasound waves to physically embed particles of different properties into textiles without using chemical binders

What does Sonovia do differently?

Capital sale of a dedicated machine and repeated sales of Sonovia's chemical formulations, i.e. the "HP" model or the "Nespresso" model

How do we make money out of it?

Companies performing applicative textile treatments for clients in fashion, transportation, hospitals, hotels, and more

What is the target market?

Technology Description	Regular soaking	Synthetic fiber	Plasma Treatment	Sono-chemical Soaking
Durability to industrial laundry	NO	YES	NO	HIGH
Durability to home laundry	MEDIUM	YES	MEDIUM	MEDIUM
Applicability to all types of textile	NO	NO	NO	YES
Cost-benefit	HIGH	LOW	LOW	HIGH
Environmental pollution and Personal infection	HIGH	HIGH	LOW	LOW

TECHNOLOGIES FOR PERFORMING APPLICATIVE TEXTILE TREATMENTS

In the US and Europe alone,

each year millions of patients hospitalized in medical institutions are infected by deadly bacteria and about 200,000 of them die.

In the US and Europe alone,

the annual economic damage to healthcare systems incurred as a result of Hospital Acquired Infections is estimated at about US\$80 Billion, and together with the damage to the economy It is estimated at about US\$160 Billion.

Textile surfaces are easily contaminated by bacteria and viruses.

Currently there is no technologically and commercially viable solution for this problem in the hospital market.

THE PROBLEM: ACQUIRED INFECTIONS IN HOSPITALS

The market of applicative treatments which is estimated at about USD 15 Billion is expected to be required by regulation and market forces to adopt green technologies

Applicative textile treatments are responsible for 20% of global water pollution.

Textiles contaminate about 9 trillion gallonsof water every year.

The increasing awareness among textile consumers throughout the world leads to a sharp increase in the scope of regulation and additional enforcementby world

leadingbrands

THE PROBLEM: ENVIRONMENTAL POLLUTION AND PERSONALINFECTION

As a result of the Cov-19 outbreak, an immediate need

arose for surface coating technologies actively and effectively extinguishing viruses and bacteria to protect the public and prevent infection

Markets which have not yet widely assimilated purification technologies, currently act actively and strategically to adopt advanced purification technologies

Sonovia: high resistance, 99% effective against viruses [including Covid-19] and bacteria

Public awareness and consciousness leads to new market competition – which company shall provide its customers with the best protection from infections

THE PROBLEM: LIVING DURING AND AFTER COV-19

11

THE TECHNOLOGY

Video Clip

13

THE BUSINESS MODEL – HP MODEL

End Use

OUR POSITION WITHIN THE VALUECHAIN

*The presented companies are examples and presented for illustration purposes only. As of the date of the presentation, Sonovia Ltd. Is not affiliated in any way with any of the companies presented and is not entitled in any way to the trademarks presented in this presentation.

2018

The Company entered into a strategic R&D agreement with the leading textile machinery corporation Bruckner Textile Machinery

2018

The Company was selected to join the world leading textile industry Fashion for Good start-up accelerator, which in addition has invested USD 230 thousand in the Company

2019

The Company received a non-diluting, partner-free grant in the sum of Euro 2.4 million* from the European Comission SME Program

2020

Technology was proven effective against Cov-19; Pilots with world leading automotive and fashion corporations; sales in excess of USD 5 million** and reaching profitability.

ACCOMPLISHMENTS

16

*As of the prospectus date, about 1.06 million EUR out of the total 2.4 million EUR have been wired to the company. **As of 30th of September 2020, Un-audited.

Sonovia's revenue potential, in terms of sale prices

The figures presented above in accordance with the chemical formulations market prices

TARGET MARKET SIZE – SUMMARY

The Products Division shall conduct, in relevant instances, market validation for Sonovia's future products and shall validate market demand before launching wide-scoped commercialization efforts.

19

In March 2020, two months after the outbreak of the Cov-19 virus, Sonovia identified an opportunity to check the market demand for the company's anti-bacterial/anti-viral application in the private market and started manufacturing branded face masks.

As of September 30, 2020, Sonovia's sales exceeded USD 5 Million* with high gross profitability. The Company expects demand for protective masks in the western world to remain stable in the foreseeable future

The Products Division proves the attractiveness of the technology and Sonovia's brand with end- consumers in the western world. Additional products shall be added in the future to increase the scope of sales.

PRODUCTS DIVISION

*Un-audited

SONOVIA - IN THE MEDIA